Back
Windtree Therapeutics Stock Price Chart
Sponsored
WINT
Sponsored
Zero Day Options Trade LIVE Tuesday at 2 p.m. ET!
Discover The Zero Day Loophole (BEFORE Tues at 2 p.m. ET!)
Sell
15
WINT
Windtree Therapeutics
Last Price:
0.35
Seasonality Move:
-8.96%
7 Day Trial
ALL ACCESS PASS
$
7
Better Than Oil Stocks
CLICK HERE TO FIND OUT MORE- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and WINT is experiencing slight buying pressure.
Windtree Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.44 | Sell |
20-day SMA: | 0.49 | Sell |
50-day SMA: | 0.75 | Sell |
200-day SMA: | 4.38 | Sell |
8-day EMA: | 0.43 | Sell |
20-day EMA: | 0.53 | Sell |
50-day EMA: | 1.25 | Sell |
200-day EMA: | 9.6 | Sell |
Windtree Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.16 | Sell |
Relative Strength Index (14 RSI): | 27.48 | Sell |
Chaikin Money Flow: | 10375 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.44 - 0.6) | Sell |
Bollinger Bands (100): | (-0.2 - 7.72) | Sell |
Windtree Therapeutics Technical Analysis
Nov 26 | Nov 27 | Nov 29 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | Dec | |||||||||
26 | 27 | 29 | 02 | 03 | 04 | 05 | 06 | 09 | 10 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Windtree Therapeutics Stock
Is Windtree Therapeutics Stock a Buy?
- Windtree Therapeutics share price is 0.37 while WINT 8-day simple moving average is 0.44, which is a Sell signal.
- The stock price of WINT is 0.37 while Windtree Therapeutics 20-day SMA is 0.49, which makes it a Sell.
- Windtree Therapeutics 50-day simple moving average is 0.75 while WINT share price is 0.37, making it a Sell technically.
- WINT stock price is 0.37 and Windtree Therapeutics 200-day simple moving average is 4.38, creating a Sell signal.
WINT Technical Analysis vs Fundamental Analysis
Sell
15
Windtree Therapeutics (WINT)
is a Sell
Is Windtree Therapeutics a Buy or a Sell?
-
Windtree Therapeutics stock is rated a Sell
The current Windtree Therapeutics [WINT] share price is $0.37. The Score for WINT is 15, which is 70% below its historic median score of 50, and infers higher risk than normal.
Windtree Therapeutics Stock Info
Market Cap:
3.33M
Price in USD:
0.37
Share Volume:
612.11K
Windtree Therapeutics 52-Week Range
52-Week High:
14.75
52-Week Low:
0.35
Sell
15
Windtree Therapeutics (WINT)
is a Sell
Windtree Therapeutics Share Price Forecast
-
What is the Windtree Therapeutics stock price today?
The Windtree Therapeutics stock price is 0.37 USD today. -
Will WINT stock go up or go down?
Windtree Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Windtree Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Windtree Therapeutics is overvalued.
Is Windtree Therapeutics Stock a Buy?
- Windtree Therapeutics share price is 0.37 while WINT 8-day exponential moving average is 0.43, which is a Sell signal.
- The stock price of WINT is 0.37 while Windtree Therapeutics 20-day EMA is 0.53, which makes it a Sell.
- Windtree Therapeutics 50-day exponential moving average is 1.25 while WINT share price is 0.37, making it a Sell technically.
- WINT stock price is 0.37 and Windtree Therapeutics 200-day simple moving average is 9.60, creating a Sell signal.
Fundamental Analysis of Windtree Therapeutics
Is Windtree Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $89.20 per share, and an increase next year of $2.80 per share.
Technical Analysis of Windtree Therapeutics
Should I short Windtree Therapeutics stock?
- WINT Moving Average Covergence Divergence (MACD) indicator is -0.16, suggesting Windtree Therapeutics is a Sell
- Windtree Therapeutics Relative Strength Index (RSI) is 27.48, which suggest Windtree Therapeutics is oversold
- The Bollinger Bands (25) for Windtree Therapeutics is (0.44 - 0.6), which suggest Windtree Therapeutics is a Sell
- The Bollinger Bands (100) for Windtree Therapeutics is (-0.2 - 7.72), which suggest Windtree Therapeutics is a Sell
* Windtree Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.